Probenecid-clofibrate interaction
- 28 February 1981
- journal article
- research article
- Published by Springer Nature in Clinical Pharmacology & Therapeutics
- Vol. 29 (3) , 351-358
- https://doi.org/10.1038/clpt.1981.48
Abstract
Clofibric acid disposition was studied in 4 healthy men after 1 wk of clofibrate ingestion (500 mg orally every 12 h) with and without probenecid (500 mg orally every 6 h). Mean (.+-. SD) free clofibric acid plasma concentration in the 4 subjects over a dosage interval at steady state was 2.5 .+-. 0.03 mg/l before and 9.05 .+-. 1.09 mg/l after the probenecid. Probenecid reached an average plasma concentration 71.3 mg/l. No clofibric acid glucuronide was detected in plasma during either treatment. The fractions of the dose recovered in urine as clofibric acid, clofibric acid glucuronide and clofibric acid liberated after acid hydrolysis were not altered by probenecid. Probenecid may reduce renal and metabolic clearance of clofibric acid, probably by inhibiting the conjugation of clofibric acid with glucuronide.This publication has 7 references indexed in Scilit:
- Pharmacokinetic and Clinical Studies of Carprofen in GoutThe Journal of Clinical Pharmacology, 1980
- The Structure of the Glucuronic Acid Conjugate of Clofibric AcidBiochemical Society Transactions, 1979
- Clofibrate disposition in renal failure and acute and chronic liver diseaseEuropean Journal of Clinical Pharmacology, 1979
- Naproxen‐probenecid interactionClinical Pharmacology & Therapeutics, 1978
- The interaction between indomethacin and probenecid; A clinical and pharmacokinetic studyClinical Pharmacology & Therapeutics, 1978
- EFFECTS OF PROBENECID UPON INDIVIDUAL COMPONENTS OF INDOMETHACIN ELIMINATION1977
- Salicylate and Salicyl Conjugates: Fluorimetric Estimation, Biosynthesis and Renal Excretion in Man1Journal of Clinical Investigation, 1958